Additional Interventions in EUS

  • Truptesh H. Kothari
  • Shivangi T. Kothari
  • Vivek KaulEmail author


The evolution of endoscopic ultrasound (EUS) from a purely diagnostic modality to one with multiple therapeutic applications has revolutionized the field of interventional endoscopy. In this chapter, we describe cutting-edge diagnostic and therapeutic EUS-guided interventions like needle-based confocal laser endomicroscopy (nCLE) and cytobrush sampling of pancreatic cystic lesions, gold fiducial placement, ethanol ablation for pancreatic cystic lesions, coil placement for GI bleeding control, and radiofrequency ablation, to name a few. Only a few of the devices used in these interventions are FDA approved and commercially available in the USA. These interventions appear feasible and are minimally invasive, thus heralding a new era in therapeutic endoscopy using the EUS platform. Further evaluation in animal studies, protocol-based human experience, and subsequent use in the field will ultimately determine the exact role and efficacy of each of these interventions in clinical practice.


Radio-frequency ablation Fiducial placement nCLE Cytobrush Brachytherapy Echoendoscope Gastrointestinal bleeding Alcohol ablation 

Supplementary material

Video 16.1

Additional interventional EUS procedures (MOV 187183 kb).


  1. 1.
    Konda VJ, Meining A, Jamil LH, Giovannini M, Hwang JH, Wallace MB, Chang KJ, Siddiqui UD, Hart J, Lo SK, et al. A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance. Endoscopy. 2013;45(12):1006–13.PubMedCrossRefGoogle Scholar
  2. 2.
    Levy MJ, Clain JE. Evaluation and management of cystic pancreatic tumors: emphasis on the role of EUS FNA. Clin Gastroenterol Hepatol. 2004;2(8):639–53.PubMedCrossRefGoogle Scholar
  3. 3.
    Hutchins GF, Draganov PV. Cystic neoplasms of the pancreas: a diagnostic challenge. World J Gastroenterol. 2009;15(1):48–54.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Attasaranya S, Pais S, LeBlanc J, McHenry L, Sherman S, DeWitt JM. Endoscopic ultrasound-guided fine needle aspiration and cyst fluid analysis for pancreatic cysts. JOP. 2007;8(5):553–63.PubMedGoogle Scholar
  5. 5.
    Meining A, Chen YK, Pleskow D, Stevens P, Shah RJ, Chuttani R, Michalek J, Slivka A. Direct visualization of indeterminate pancreaticobiliary strictures with probe-based confocal laser endomicroscopy: a multicenter experience. Gastrointest Endosc. 2011;74(5):961–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Gaddam S, Mathur SC, Singh M, Arora J, Wani SB, Gupta N, Overhiser A, Rastogi A, Singh V, Desai N, et al. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett’s esophagus. Am J Gastroenterol. 2011;106(11):1961–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Giovannini M, Caillol F, Lemaistre A, et al. Endoscopic ultrasound guided confocal microscopy: Atlas of cystic pancreatic lesions. Endosc Ultrasound. 2014;3:S19–21.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Konda VJ, Aslanian HR, Wallace MB, Siddiqui UD, Hart J, Waxman I. First assessment of needle-based confocal laser endomicroscopy during EUS-FNA procedures of the pancreas (with videos). Gastrointest Endosc. 2011;74(5):1049–60.PubMedCrossRefGoogle Scholar
  9. 9.
    Nakai Y, Iwashita T, Park DH, Samarasena JB, Lee JG, Chang KJ. Diagnosis of pancreatic cysts: EUS-guided, through-the-needle confocal laser-induced endomicroscopy and cystoscopy trial: DETECT study. Gastrointest Endosc. 2015.Google Scholar
  10. 10.
    Al-Haddad M, Raimondo M, Woodward T, Krishna M, Pungpapong S, Noh K, Wallace MB. Safety and efficacy of cytology brushings versus standard FNA in evaluating cystic lesions of the pancreas: a pilot study. Gastrointest Endosc. 2007;65(6):894–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Lozano MD, Subtil JC, Miravalles TL, Echeveste JI, Prieto C, Betes M, Alvarez Cienfuegos FJ, Idoate MA. EchoBrush may be superior to standard EUS-guided FNA in the evaluation of cystic lesions of the pancreas: preliminary experience. Cancer Cytopathol. 2011;119(3):209–14.PubMedCrossRefGoogle Scholar
  12. 12.
    Al-Haddad M, Gill KR, Raimondo M, Woodward TA, Krishna M, Crook JE, Skarvinko LN, Jamil LH, Hasan M, Wallace MB. Safety and efficacy of cytology brushings versus standard fine-needle aspiration in evaluating cystic pancreatic lesions: a controlled study. Endoscopy. 2010;42(2):127–32.PubMedCrossRefGoogle Scholar
  13. 13.
    Al-Haddad M, Eloubeidi MA. Interventional EUS for the diagnosis and treatment of locally advanced pancreatic cancer. JOP. 2010;11(1):1–7.PubMedGoogle Scholar
  14. 14.
    Majumder S, Berzin TM, Mahadevan A, Pawa R, Ellsmere J, Sepe PS, Larosa SA, Pleskow DK, Chuttani R, Sawhney MS. Endoscopic ultrasound-guided pancreatic fiducial placement: how important is ideal fiducial geometry? Pancreas. 2013;42(4):692–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Davila Fajardo R, Lekkerkerker SJ, van der Horst A, Lens E, Bergman JJ, Fockens P, Bel A, van Hooft JE. EUS-guided fiducial markers placement with a 22-gauge needle for image-guided radiation therapy in pancreatic cancer. Gastrointest Endosc. 2014;79(5):851–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Pishvaian AC, Collins B, Gagnon G, Ahlawat S, Haddad NG. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc. 2006;64(3):412–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Choi JH, Seo DW, Park do H, Lee SK, Kim MH. Fiducial placement for stereotactic body radiation therapy under only endoscopic ultrasonography guidance in pancreatic and hepatic malignancy: practical feasibility and safety. Gut Liver. 2014;8(1):88–93.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Zhongmin W, Yu L, Fenju L, Kemin C, Gang H. Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. Eur Radiol. 2010;20(7):1786–91.PubMedCrossRefGoogle Scholar
  19. 19.
    Kishi K, Sonomura T, Shirai S, Noda Y, Sato M, Kawai M, Yamaue H. Brachytherapy reirradiation with hyaluronate gel injection of paraaortic lymphnode metastasis of pancreatic cancer: paravertebral approach—a technical report with a case. J Radiat Res. 2011;52(6):840–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Sun S, Qingjie L, Qiyong G, Mengchun W, Bo Q, Hong X. EUS-guided interstitial brachytherapy of the pancreas: a feasibility study. Gastrointest Endosc. 2005;62(5):775–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Sun S, Xu H, Xin J, Liu J, Guo Q, Li S. Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial. Endoscopy. 2006;38(4):399–403.PubMedCrossRefGoogle Scholar
  22. 22.
    Jin Z, Du Y, Li Z, Jiang Y, Chen J, Liu Y. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy. 2008;40(4):314–20.PubMedCrossRefGoogle Scholar
  23. 23.
    Omerovic S, Zerem E. Alcohol sclerotherapy in the treatment of symptomatic simple renal cysts. Bosn J Basic Med Sci. 2008;8(4):337–40.PubMedGoogle Scholar
  24. 24.
    Larssen TB, Jensen DK, Viste A, Horn A. Single-session alcohol sclerotherapy in symptomatic benign hepatic cysts. Long-term results. Acta Radiol. 1999;40(6):636–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, Salmi A, Torzilli G. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer. 1992;69(4):925–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Xiao YY, Tian JL, Li JK, Yang L, Zhang JS. CT-guided percutaneous chemical ablation of adrenal neoplasms. AJR Am J Roentgenol. 2008;190(1):105–10.PubMedCrossRefGoogle Scholar
  27. 27.
    Bean WJ, Rodan BA. Hepatic cysts: treatment with alcohol. AJR Am J Roentgenol. 1985;144(2):237–41.PubMedCrossRefGoogle Scholar
  28. 28.
    Gelczer RK, Charboneau JW, Hussain S, Brown DL. Complications of percutaneous ethanol ablation. J Ultrasound Med. 1998;17(8):531–3.PubMedGoogle Scholar
  29. 29.
    Goh BK, Tan YM, Cheow PC, Chung YF, Chow PK, Wong WK, Ooi LL. Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years. Am J Surg. 2006;192(2):148–54.PubMedCrossRefGoogle Scholar
  30. 30.
    Oh HC, Seo DW. Endoscopic ultrasonography-guided pancreatic cyst ablation (with video). J Hepatobiliary Pancreat Sci. 2015;22(1):16–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Oh HC, Seo DW, Song TJ, Moon SH, Park do H, Soo Lee S, Lee SK, Kim MH, Kim J. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology. 2011;140(1):172–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Gan SI, Thompson CC, Lauwers GY, Bounds BC, Brugge WR. Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc. 2005;61(6):746–52.PubMedCrossRefGoogle Scholar
  33. 33.
    DeWitt J, McGreevy K, Schmidt CM, Brugge WR. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc. 2009;70(4):710–23.PubMedCrossRefGoogle Scholar
  34. 34.
    Oh HC, Seo DW, Lee TY, Kim JY, Lee SS, Lee SK, Kim MH. New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc. 2008;67(4):636–42.PubMedCrossRefGoogle Scholar
  35. 35.
    DeWitt JM, Al-Haddad M, Sherman S, LeBlanc J, Schmidt CM, Sandrasegaran K, Finkelstein SD. Alterations in cyst fluid genetics following endoscopic ultrasound-guided pancreatic cyst ablation with ethanol and paclitaxel. Endoscopy. 2014;46(6):457–64.PubMedCrossRefGoogle Scholar
  36. 36.
    DeWitt J. Endoscopic ultrasound-guided pancreatic cyst ablation. Gastrointest Endosc Clin N Am. 2012;22(2):291–302. ix-x.PubMedCrossRefGoogle Scholar
  37. 37.
    Khashab MA, Shin EJ, Amateau S, Canto MI, Hruban RH, Fishman EK, Cameron JL, Edil BH, Wolfgang CL, Schulick RD, et al. Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms. Am J Gastroenterol. 2011;106(8):1521–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Jurgensen C, Schuppan D, Neser F, Ernstberger J, Junghans U, Stolzel U. EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc. 2006;63(7):1059–62.PubMedCrossRefGoogle Scholar
  39. 39.
    Gunter E, Lingenfelser T, Eitelbach F, Muller H, Ell C. EUS-guided ethanol injection for treatment of a GI stromal tumor. Gastrointest Endosc. 2003;57(1):113–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Artifon EL, Lucon AM, Sakai P, Gerhardt R, Srougi M, Takagaki T, Ishioka S, Bhutani MS. EUS-guided alcohol ablation of left adrenal metastasis from non-small-cell lung carcinoma. Gastrointest Endosc. 2007;66(6):1201–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Barclay RL, Perez-Miranda M, Giovannini M. EUS-guided treatment of a solid hepatic metastasis. Gastrointest Endosc. 2002;55(2):266–70.PubMedCrossRefGoogle Scholar
  42. 42.
    DeWitt J, Mohamadnejad M. EUS-guided alcohol ablation of metastatic pelvic lymph nodes after endoscopic resection of polypoid rectal cancer: the need for long-term surveillance. Gastrointest Endosc. 2011;74(2):446–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Soehendra N, Nam VC, Grimm H, Kempeneers I. Endoscopic obliteration of large esophagogastric varices with bucrylate. Endoscopy. 1986;18(1):25–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD, Practice Guidelines Committee of American Association for Study of Liver D, Practice Parameters Committee of American College of G. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol. 2007;102(9):2086–102.PubMedCrossRefGoogle Scholar
  45. 45.
    de Franchis R, Baveno VF. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53(4):762–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Irani S, Kowdley K, Kozarek R. Gastric varices: an updated review of management. J Clin Gastroenterol. 2011;45(2):133–48.PubMedCrossRefGoogle Scholar
  47. 47.
    Binmoeller KF, Weilert F, Shah JN, Kim J. EUS-guided transesophageal treatment of gastric fundal varices with combined coiling and cyanoacrylate glue injection (with videos). Gastrointest Endosc. 2011;74(5):1019–25.PubMedCrossRefGoogle Scholar
  48. 48.
    Lee YT, Chan FK, Ng EK, Leung VK, Law KB, Yung MY, Chung SC, Sung JJ. EUS-guided injection of cyanoacrylate for bleeding gastric varices. Gastrointest Endosc. 2000;52(2):168–74.PubMedCrossRefGoogle Scholar
  49. 49.
    Romero-Castro R, Pellicer-Bautista FJ, Jimenez-Saenz M, Marcos-Sanchez F, Caunedo-Alvarez A, Ortiz-Moyano C, Gomez-Parra M, Herrerias-Gutierrez JM. EUS-guided injection of cyanoacrylate in perforating feeding veins in gastric varices: results in 5 cases. Gastrointest Endosc. 2007;66(2):402–7.PubMedCrossRefGoogle Scholar
  50. 50.
    Levy MJ, Wong Kee Song LM, Kendrick ML, Misra S, Gostout CJ. EUS-guided coil embolization for refractory ectopic variceal bleeding (with videos). Gastrointest Endosc. 2008;67(3):572–4.PubMedCrossRefGoogle Scholar
  51. 51.
    Puri R, Eloubeidi MA, Sud R, Kumar M, Jain P. Endoscopic ultrasound-guided drainage of pelvic abscess without fluoroscopy guidance. J Gastroenterol Hepatol. 2010;25(8):1416–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Ulla-Rocha JL, Vilar-Cao Z, Sardina-Ferreiro R. EUS-guided drainage and stent placement for postoperative intra-abdominal and pelvic fluid collections in oncological surgery. Therap Adv Gastroenterol. 2012;5(2):95–102.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Trevino JM, Drelichman ER, Varadarajulu S. Modified technique for EUS-guided drainage of pelvic abscess (with video). Gastrointest Endosc. 2008;68(6):1215–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Giovannini M, Bories E, Moutardier V, Pesenti C, Guillemin A, Lelong B, Delpero JR. Drainage of deep pelvic abscesses using therapeutic echo endoscopy. Endoscopy. 2003;35(6):511–4.PubMedCrossRefGoogle Scholar
  55. 55.
    Varadarajulu S, Drelichman ER. Effectiveness of EUS in drainage of pelvic abscesses in 25 consecutive patients (with video). Gastrointest Endosc. 2009;70(6):1121–7.PubMedCrossRefGoogle Scholar
  56. 56.
    Jang JW, Lee SS, Song TJ, Hyun YS, Park do H, Seo DW, Lee SK, Kim MH, Yun SC. Endoscopic ultrasound-guided transmural and percutaneous transhepatic gallbladder drainage are comparable for acute cholecystitis. Gastroenterology. 2012;142(4):805–11.PubMedCrossRefGoogle Scholar
  57. 57.
    Hasan MK, Itoi T, Varadarajulu S. Endoscopic management of acute cholecystitis. Gastrointest Endosc Clin N Am. 2013;23(2):453–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Choi JH, Lee SS, Choi JH, Park do H, Seo DW, Lee SK, Kim MH. Long-term outcomes after endoscopic ultrasonography-guided gallbladder drainage for acute cholecystitis. Endoscopy. 2014;46(8):656–61.PubMedCrossRefGoogle Scholar
  59. 59.
    Penas-Herrero I, de la Serna-Higuera C, Perez-Miranda M. Endoscopic ultrasound-guided gallbladder drainage for the management of acute cholecystitis (with video). J Hepatobiliary Pancreat Sci. 2015;22(1):35–43.PubMedCrossRefGoogle Scholar
  60. 60.
    de la Serna-Higuera C, Perez-Miranda M, Gil-Simon P, Ruiz-Zorrilla R, Diez-Redondo P, Alcaide N, Sancho-del Val L, Nunez-Rodriguez H. EUS-guided transenteric gallbladder drainage with a new fistula-forming, lumen-apposing metal stent. Gastrointest Endosc. 2013;77(2):303–8.PubMedCrossRefGoogle Scholar
  61. 61.
    Widmer J, Alvarez P, Gaidhane M, Paddu N, Umrania H, Sharaiha R, Kahaleh M. Endoscopic ultrasonography-guided cholecystogastrostomy in patients with unresectable pancreatic cancer using anti-migratory metal stents: a new approach. Dig Endosc. 2014;26(4):599–602.PubMedCrossRefGoogle Scholar
  62. 62.
    Binmoeller KF, Shah J. A novel lumen-apposing stent for transluminal drainage of nonadherent extraintestinal fluid collections. Endoscopy. 2011;43(4):337–42.PubMedCrossRefGoogle Scholar
  63. 63.
    Moon JH, Choi HJ, Kim DC, Lee YN, Kim HK, Jeong SA, Lee TH, Cha SW, Cho YD, Park SH, et al. A newly designed fully covered metal stent for lumen apposition in EUS-guided drainage and access: a feasibility study (with videos). Gastrointest Endosc. 2014;79(6):990–5.PubMedCrossRefGoogle Scholar
  64. 64.
    Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer. 1995;76(9):1671–7.PubMedCrossRefGoogle Scholar
  65. 65.
    Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med. 1992;326(7):455–65.PubMedCrossRefGoogle Scholar
  66. 66.
    Wu Y, Tang Z, Fang H, Gao S, Chen J, Wang Y, Yan H. High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol. 2006;94(5):392–5.PubMedCrossRefGoogle Scholar
  67. 67.
    Spiliotis JD, Datsis AC, Michalopoulos NV, Kekelos SP, Vaxevanidou A, Rogdakis AG, Christopoulou AN. High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol. 2007;96(1):89–90.PubMedCrossRefGoogle Scholar
  68. 68.
    Sethi A, Ellrichmann M, Dhar S, Hadeler KG, Kahle E, Seehusen F, Klapper W, Habib N, Fritscher-Ravens A. Endoscopic ultrasound-guided lymph node ablation with a novel radiofrequency ablation probe: feasibility study in an acute porcine model. Endoscopy. 2014;46(5):411–5.PubMedCrossRefGoogle Scholar
  69. 69.
    Goldberg SN, Mallery S, Gazelle GS, Brugge WR. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc. 1999;50(3):392–401.PubMedCrossRefGoogle Scholar
  70. 70.
    Carrara S, Arcidiacono PG, Albarello L, Addis A, Enderle MD, Boemo C, Campagnol M, Ambrosi A, Doglioni C, Testoni PA. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy. 2008;40(4):321–6.PubMedCrossRefGoogle Scholar
  71. 71.
    Kushibiki T, Hirasawa T, Okawa S, Ishihara M. Responses of cancer cells induced by photodynamic therapy. J healthc Eng. 2013;4(1):87–108.PubMedCrossRefGoogle Scholar
  72. 72.
    Chan HH, Nishioka NS, Mino M, Lauwers GY, Puricelli WP, Collier KN, Brugge WR. EUS-guided photodynamic therapy of the pancreas: a pilot study. Gastrointest Endosc. 2004;59(1):95–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Yusuf TE, Matthes K, Brugge WR. EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video). Gastrointest Endosc. 2008;67(6):957–61.PubMedCrossRefGoogle Scholar
  74. 74.
    Di Matteo F, Martino M, Rea R, Pandolfi M, Rabitti C, Masselli GM, Silvestri S, Pacella CM, Papini E, Panzera F, et al. EUS-guided Nd:YAG laser ablation of normal pancreatic tissue: a pilot study in a pig model. Gastrointest Endosc. 2010;72(2):358–63.PubMedCrossRefGoogle Scholar
  75. 75.
    Di Matteo F, Martino M, Rea R, Pandolfi M, Panzera F, Stigliano E, Schena E, Saccomandi P, Silvestri S, Pacella CM, et al. US-guided application of Nd:YAG laser in porcine pancreatic tissue: an ex vivo study and numerical simulation. Gastrointest Endosc. 2013;78(5):750–5.PubMedCrossRefGoogle Scholar
  76. 76.
    Chang KJ, Nguyen PT, Thompson JA, Kurosaki TT, Casey LR, Leung EC, Granger GA. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer. 2000;88(6):1325–35.PubMedCrossRefGoogle Scholar
  77. 77.
    Mulvihill S, Warren R, Venook A, Adler A, Randlev B, Heise C, Kirn D. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Ther. 2001;8(4):308–15.PubMedCrossRefGoogle Scholar
  78. 78.
    Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM, Kirn DH, Freeman SM. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res. 2003;9(2):555–61.PubMedGoogle Scholar
  79. 79.
    Chang KJ, Lee JG, Holcombe RF, Kuo J, Muthusamy R, Wu ML. Endoscopic ultrasound delivery of an antitumor agent to treat a case of pancreatic cancer. Nat Clin Pract Gastroenterol Hepatol. 2008;5(2):107–11.PubMedCrossRefGoogle Scholar
  80. 80.
    Chang KJ, Irisawa A, Group EUSW. EUS 2008 Working Group document: evaluation of EUS-guided injection therapy for tumors. Gastrointest Endosc. 2009;69(2 Suppl):S54–8.PubMedCrossRefGoogle Scholar
  81. 81.
    Hecht JR, Farrell JJ, Senzer N, Nemunaitis J, Rosemurgy A, Chung T, Hanna N, Chang KJ, Javle M, Posner M, et al. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012;75(2):332–8.PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Herman JM, Wild AT, Wang H, Tran PT, Chang KJ, Taylor GE, Donehower RC, Pawlik TM, Ziegler MA, Cai H, et al. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. Journal Clin Oncol. 2013;31(7):886–94.CrossRefGoogle Scholar
  83. 83.
    Citrin D, Camphausen K, Wood BJ, Quezado M, Denobile J, Pingpank JF, Royal RE, Alexander HR, Seidel G, Steinberg SM, et al. A pilot feasibility study of TNFerade biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer. Oncology. 2010;79(5-6):382–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Akiyama Y, Maruyama K, Nara N, Hojo T, Cheng JY, Mori T, Wiltrout RH, Yamaguchi K. Antitumor effects induced by dendritic cell-based immunotherapy against established pancreatic cancer in hamsters. Cancer Lett. 2002;184(1):37–47.PubMedCrossRefGoogle Scholar
  85. 85.
    Irisawa A, Takagi T, Kanazawa M, Ogata T, Sato Y, Takenoshita S, Ohto H, Ohira H. Endoscopic ultrasound-guided fine-needle injection of immature dendritic cells into advanced pancreatic cancer refractory to gemcitabine: a pilot study. Pancreas. 2007;35(2):189–90.PubMedCrossRefGoogle Scholar
  86. 86.
    Hirooka Y, Itoh A, Kawashima H, Hara K, Nonogaki K, Kasugai T, Ohno E, Ishikawa T, Matsubara H, Ishigami M, et al. A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Pancreas. 2009;38(3):e69–74.PubMedCrossRefGoogle Scholar
  87. 87.
    Endo H, Saito T, Kenjo A, Hoshino M, Terashima M, Sato T, Anazawa T, Kimura T, Tsuchiya T, Irisawa A, et al. Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients. J Hepatobiliary Pancreat Sci. 2012;19(4):465–75.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Truptesh H. Kothari
    • 1
    • 2
  • Shivangi T. Kothari
    • 1
    • 2
  • Vivek Kaul
    • 1
    • 2
    Email author
  1. 1.Division of Gastroenterology and HepatologyUniversity of Rochester Medical Center & Strong Memorial HospitalRochesterUSA
  2. 2.Center for Advanced Therapeutic EndoscopyURMC/Strong Memorial HospitalRochesterUSA

Personalised recommendations